New Data in the Treatment of METex14-skipping Advanced NSCLC

S

The VISION Trial: Tepotinib in Patients With NSCLC Harboring METex14 Skipping Mutation

By Santiago Viteri
143 views
May 10, 2024
Comments 0
Login to view comments. Click here to Login
17:51

WCLC 2024 Insights: Biology of CNS Metastases in NSCLC

Insights from 2024 WCLC

T. Burns

157 views
17:35

Strategies for Managing Toxicities of Oral Oncolytics in Lung Cancer…

UNC Lineberger Comprehensive Cancer Center

K. Chen, A. Faso, B. Patel

106 views
16:12

2024 Updates on the Fast-Changing NSCLC Landscape

Total Health

R. Osarogiagbon

457 views
06:09

Perioperative vs. Preoperative Surgery in NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

413 views
09:24

Comparative Analysis of PFS & OS in 1L Treatment With Tepotinib vs. …

Frank Griesinger

128 views
07:55

MET Exon 14 Skipping Mutations in NSCLC

MI&T Congressi

O. Gautschi

200 views
10:14

Precision Medicine in NSCLC

UChicago Medicine 12th International Clinical Cancer Genomics Conference

S. Gray

289 views
16:16

Clinical Insights on the Management of Edema Associated With MET Inh…

Lorenzo Belluomini

240 views